The human α-ICOSL antibody AMG 557, for example, proved efficacious in diminishing isotype-switched Ab production, but not IgM production, in SLE patients challenged nasally with KLH in a phase I clinical trial (124). Here, CD40LG is linked to systemic lupus erythematosus.